Evidence map›Paper›PMID 30254117›Full record

ArticlemBio2018

Antagonistic Pleiotropy in the Bifunctional Surface Protein FadL (OmpP1) during Adaptation of Haemophilus influenzae to Chronic Lung Infection Associated with Chronic Obstructive Pulmonary Disease.

Javier Moleres, Ariadna Fernández-Calvet, Rachel L Ehrlich, Sara Martí, Lucía Pérez-Regidor, Begoña Euba, Irene Rodríguez-Arce, Sergey Balashov, Ester Cuevas, Josefina Liñares and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 43 citations in OpenAlex.

  1. ThemBio · 2026
    Article
  2. Article
  3. Article
  4. Virulence factors ofFrontiers in microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Bacterial acquisition of host fatty acids has far-reaching implications on virulence.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Microbiology spectrum · 2023
    Article
  16. Article
  17. Imipenem heteroresistance but not tolerance inFrontiers in microbiology · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Javier Moleres *Instituto de Agrobiotecnología, CSIC-Universidad Pública Navarra-Gobierno Navarra, Mutilva, Spain.
Ariadna Fernández-Calvet *Instituto de Agrobiotecnología, CSIC-Universidad Pública Navarra-Gobierno Navarra, Mutilva, Spain.
Rachel L EhrlichDepartment of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Sara MartíCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Lucía Pérez-RegidorDepartment of Structural and Chemical Biology, Centro de Investigaciones Biológicas, CIB-CSIC, Madrid, Spain.
Begoña EubaInstituto de Agrobiotecnología, CSIC-Universidad Pública Navarra-Gobierno Navarra, Mutilva, Spain.
Irene Rodríguez-ArceInstituto de Agrobiotecnología, CSIC-Universidad Pública Navarra-Gobierno Navarra, Mutilva, Spain.
Sergey BalashovDepartment of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Ester CuevasPneumology Department, Hospital Universitari Bellvitge, University of Barcelona, IDIBELL, Barcelona, Spain.
Josefina LiñaresCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Carmen ArdanuyCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Sonsoles Martín-SantamaríaDepartment of Structural and Chemical Biology, Centro de Investigaciones Biológicas, CIB-CSIC, Madrid, Spain.
Garth D EhrlichDepartment of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Joshua Chang MellDepartment of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA jcm385@drexel.edu juncal.garmendia@unavarra.es.
Junkal GarmendiaInstituto de Agrobiotecnología, CSIC-Universidad Pública Navarra-Gobierno Navarra, Mutilva, Spain jcm385@drexel.edu juncal.garmendia@unavarra.es.
Agrobiotechnology Institute · ESInstitute for Molecular Medicine · USBellvitge University Hospital · ESCentro de Investigaciones Biológicas Margarita Salas · ESUniversitat de Barcelona · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESDrexel University · US

Funding

MAPP Research NetworkU01DK082316 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LANDIS, J RICHARD · 2008 to 2018
$17.2M
MOLECULAR ANALYSIS OF PATHOGENS IN OTITIS MEDIA BY PCRR01DC002148 · NIDCD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EHRLICH, GARTH D. · 1994 to 2017
$6.5M
NIDCD NIH HHS R01 DC002148NIDDK NIH HHS U01 DK082316
6 · The paper itself

Abstract

Tracking bacterial evolution during chronic infection provides insights into how host selection pressures shape bacterial genomes. The human-restricted opportunistic pathogen nontypeable

Indexed as

Adaptation, BiologicalAgedAged, 80 and overBacterial Outer Membrane ProteinsComputational BiologyFatty Acid Transport ProteinsGenetic VariationGenome, BacterialHaemophilus InfectionsHaemophilus influenzaeHumansLongitudinal StudiesMiddle AgedMolecular Docking SimulationMutationPneumonia, BacterialBacterial Outer Membrane ProteinsFatty Acid Transport Proteinsadaptive evolutionantagonistic pleiotropicCEACAM1chronic obstructive pulmonary diseasecomparative genomicsconvergent evolutionFadL/OmpP1free fatty acidsHaemophilus influenzaein situ evolution

Identifiers

PMID30254117
PMCPMC6156194
OpenAlexW2892922444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.